COP vs ORGO · P/E 19, rev $58.94B vs rev $482.0M
ConocoPhillips (COP) versus Organogenesis Holdings Inc (ORGO) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported ORGO revenue for 2024-12-31 was $482.0M. Net income was $861.0K. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. ORGO currently screens at market cap $301.1M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. ORGO currently screens at market cap $301.1M.
Not investment advice. Open the COP and ORGO stock pages for the full models.
Not investment advice.